- Home
- GH vs RUSHA Comparison
GH vs RUSHA Comparison
Compare GH & RUSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- RUSHA
- Stock Information
- Founded
- GH 2011
- RUSHA 1965
- Country
- GH United States
- RUSHA United States
- Employees
- GH N/A
- RUSHA N/A
- Industry
- GH Medical Specialities
- RUSHA Retail-Auto Dealers and Gas Stations
- Sector
- GH Health Care
- RUSHA Consumer Discretionary
- Exchange
- GH Nasdaq
- RUSHA Nasdaq
- Market Cap
- GH 4.9B
- RUSHA 4.5B
- IPO Year
- GH 2018
- RUSHA 1996
- Fundamental
- Price
- GH $54.62
- RUSHA $56.05
- Analyst Decision
- GH Strong Buy
- RUSHA Buy
- Analyst Count
- GH 17
- RUSHA 1
- Target Price
- GH $58.24
- RUSHA $61.00
- AVG Volume (30 Days)
- GH 2.4M
- RUSHA 266.1K
- Earning Date
- GH 11-05-2025
- RUSHA 10-28-2025
- Dividend Yield
- GH N/A
- RUSHA 1.37%
- EPS Growth
- GH N/A
- RUSHA N/A
- EPS
- GH N/A
- RUSHA 3.51
- Revenue
- GH $828,849,000.00
- RUSHA $7,687,256,000.00
- Revenue This Year
- GH $28.07
- RUSHA N/A
- Revenue Next Year
- GH $21.61
- RUSHA $9.71
- P/E Ratio
- GH N/A
- RUSHA $15.85
- Revenue Growth
- GH 28.74
- RUSHA N/A
- 52 Week Low
- GH $20.14
- RUSHA $47.06
- 52 Week High
- GH $68.00
- RUSHA $65.43
- Technical
- Relative Strength Index (RSI)
- GH 41.10
- RUSHA 46.71
- Support Level
- GH $53.67
- RUSHA $56.54
- Resistance Level
- GH $61.95
- RUSHA $59.35
- Average True Range (ATR)
- GH 2.29
- RUSHA 1.24
- MACD
- GH -1.51
- RUSHA -0.36
- Stochastic Oscillator
- GH 7.33
- RUSHA 16.15
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About RUSHA Rush Enterprises Inc. Cl A
Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States and Ontario, Canada commercial vehicle markets and related aftermarkets.